Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on August 21st, 2019%
National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants. . . . → Read More: Small Biz Grant Funds Pre-Term Gut Microbe Therapy
By Alan, on August 20th, 2019%
A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine
By Alan, on August 20th, 2019%
Engineers in Europe developed an electronic device that connects to and stimulates the optic nerve, producing simple visual patterns in lab animals. . . . → Read More: Optic Nerve Stimulation Developed as Visual Prosthetic
By Alan, on August 19th, 2019%
A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial
By Alan, on August 19th, 2019%
An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round. . . . → Read More: Aging Therapy Network Adds $100M to Venture Round
By Alan, on August 17th, 2019%
Statista prepared a chart this week with data from an annual report by the Intellectual Property Owners Association, this weekend’s infographic on Science & Enterprise. . . . → Read More: Infographic – IBM Leads Again in Patent Awards
By Alan, on August 16th, 2019%
An engineering team designed sensors that stick on the skin and form a network with radio-frequency signals to track physiological functions. . . . → Read More: Skin Sensor Network Tracks Health Functions
By Alan, on August 16th, 2019%
A new project examines brain pathologies leading to development of Alzheimer’s disease in Americans of Hispanic descent, a group largely ignored in neuroscience. . . . → Read More: Hispanic Neuro Disease Landscape Mapped in New Study
By Alan, on August 15th, 2019%
A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer. . . . → Read More: Controlled Brain Tumor Gene Therapy Shown Safe
By Alan, on August 14th, 2019%
Medical and engineering researchers developed fibers made with nanoscale carbon tubes that in lab animals conducted electrical signals and repaired heart damage. . . . → Read More: Nanotube Fibers Configured for Heart Repair
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|